NS-398

TargetMol
Product Code: TAR-T3214
Supplier: TargetMol
CodeSizePrice
TAR-T3214-2mg2mg£95.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3214-5mg5mg£107.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3214-1mL1 mL * 10 mM (in DMSO)£111.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3214-10mg10mg£119.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3214-25mg25mg£148.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3214-50mg50mg£221.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3214-100mg100mg£302.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T3214-200mg200mg£371.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
NS-398 is a COX-2 inhibitor wih anti-inflammatory activity.
CAS:
123653-11-2
Formula:
C13H18N2O5S
Molecular Weight:
314.36
Pathway:
Neuroscience; Immunology/Inflammation
Purity:
0.9972
SMILES:
CS(=O)(=O)Nc1ccc(cc1OC1CCCCC1)[N+]([O-])=O
Target:
COX

References

1. Futaki N, et al. Prostaglandins. 1994, 47(1):55-9. 2. Meyer-Siegler K, et al. Mol Med. 2001, 7(12):850-60. 3. Sun Y, et al. Sci Rep. 2016, 6:22573. 4. Wang Z, Liu P, Hu M, et al. A Research Article Submitted to Journal of Ethnopharmacology Naoxintong restores Ischemia Injury and inhibits Thrombosis via COX2-VEGF/NF?B Signaling[J]. Journal of Ethnopharmacology. 2021: 113809. 5. Wang H, Hu Y, He F, et al. All-trans retinoic acid and COX-2 cross-talk to regulate BMP9-induced osteogenic differentiation via Wnt/?-catenin in mesenchymal stem cells[J]. Biomedicine & Pharmacotherapy. 2019, 118: 109279.